Skip to content
Back to all stories
TechCrunch

Proximal Ventures raises debut fund to back startups bringing AI to drug development

Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma

By TechCrunch

Excerpt shared by Lazyfounder

·Excerpt
Proximal Ventures raises debut fund to back startups bringing AI to drug development
Image: Image Credits:Proximal Ventures

While established venture firms continue to attract capital, first-time fund managers are facing one of the toughest fundraising environments in years. But that didn’t stop Sahir Raoof, a former SignalFire investor and executive at two healthcare startups, from raising $27.5 million for his first solo VC fund.

Raoof’s firm, Proximal Ventures, is betting that AI can transform the tools, infrastructure, and services that support drug development.

Continue reading on TechCrunch ↗

Courtesy

This story was originally published by TechCrunch. All rights belong to the original publisher.

Read the original on techcrunch.com ↗
Lazy Founder - Powered by Blogy.in

Contact us

Have a story tip, correction or partnership idea?

Write to us at tarun.kumar@blogy.in or talk to the founder directly. We read every message.

Contact us